AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34628376 — intervention group
Group type: EXPERIMENTAL
Intervention: Nano-ceramic photocomposite
Number of subjects: 0
Study 34628376 — intervention group
Group type: EXPERIMENTAL
Intervention: Microhybrid photocomposite
Number of subjects: 0
Study 34628376 — intervention group
Group type: EXPERIMENTAL
Intervention: Microfilled photocomposite
Number of subjects: 0
Study 34628376 — intervention group
Group type: EXPERIMENTAL
Intervention: Nanofilled photocomposite
Number of subjects: 0
Study 35388666 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral tebipenem pivoxil hydrobromide (600 mg every 8 hours)
Number of subjects: 1372
Study 35388666 — intervention group
Group type: COMPARATOR
Intervention: Intravenous ertapenem (1 g every 24 hours)
Number of subjects: 1372
Study 35388666 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral tebipenem pivoxil hydrobromide
Number of subjects: 1372
Study 35388666 — intervention group
Group type: COMPARATOR
Intervention: Intravenous ertapenem
Number of subjects: 1372
Study 32567438 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent vascular occlusion (IVO)
Number of subjects: 12
Study 32567438 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 12
Study 32303206 — intervention group
Group type: EXPERIMENTAL
Intervention: Test toothpaste (sodium fluoride toothpaste containing lactate ion and polyvinylmethylether‐maleic anhydride)
Number of subjects: 62
Study 32303206 — intervention group
Group type: COMPARATOR
Intervention: Reference toothpaste (stannous fluoride‐zinc citrate, SnF2‐Zn)
Number of subjects: 62
Study 32303206 — intervention group
Group type: COMPARATOR
Intervention: Placebo toothpaste (fluoride-free)
Number of subjects: 62
Study 32303206 — intervention group
Group type: EXPERIMENTAL
Intervention: Test toothpaste
Number of subjects: 62
Study 35220995 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (structured exercise programme with physiotherapy, 3-6 appointments)
Number of subjects: 392
Study 35220995 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group
Number of subjects: 392
Study 35220995 — intervention group
Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 392
Study 33188693 — intervention group
Group type: EXPERIMENTAL
Intervention: Vadadustat
Number of subjects: 3923
Study 33188693 — intervention group
Group type: COMPARATOR
Intervention: Darbepoetin alfa (ESA)
Number of subjects: 3923
Study 32805198 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic risk score for systolic blood pressure (GRSSBP)
Number of subjects: 0
Study 32805198 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic risk score for diastolic blood pressure (GRSDBP)
Number of subjects: 0
Study 32805198 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic risk score for mean arterial pressure (GRSMAP)
Number of subjects: 0
Study 32805198 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic risk score for pulse pressure (GRSPP)
Number of subjects: 0
Study 32805198 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic risk score for hypertension (GRSHTN)
Number of subjects: 0
Study 32805198 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined genetic risk score (GRScomb)
Number of subjects: 0
Study 36145064 — intervention group
Group type: EXPERIMENTAL
Intervention: Fava bean protein (FBP) 0.33 g·kg‐1
Number of subjects: 16
Study 36145064 — intervention group
Group type: COMPARATOR
Intervention: Negative control (EAA‐free mixture)
Number of subjects: 16
Study 36145064 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 16
Study 34407776 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted navigation (CAS) TKA
Number of subjects: 50
Study 34407776 — intervention group
Group type: COMPARATOR
Intervention: Conventional TKA
Number of subjects: 50
Study 32424935 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.8 mg/d liraglutide
Number of subjects: 84
Study 32424935 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study 33319249 — intervention group
Group type: EXPERIMENTAL
Intervention: TAK-003
Number of subjects: 20099
Study 34473788 — intervention group
Group type: EXPERIMENTAL
Intervention: VPI with MI tasks (combined condition)
Number of subjects: 20
Study 34473788 — intervention group
Group type: EXPERIMENTAL
Intervention: MI condition
Number of subjects: 20
Study 34473788 — intervention group
Group type: COMPARATOR
Intervention: VPI condition
Number of subjects: 20
Study 34438364 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood flow restriction (BFR) resistance training
Number of subjects: 4
Study 34438364 — intervention group
Group type: COMPARATOR
Intervention: High- or low-load resistance training
Number of subjects: 4
Study 34053489 — intervention group
Group type: EXPERIMENTAL
Intervention: ICP+PbtO2 monitoring group
Number of subjects: 70
Study 34053489 — intervention group
Group type: COMPARATOR
Intervention: ICP monitoring group
Number of subjects: 70
Study 35640182 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional non-removable orthodontic device (FNT)
Number of subjects: 83
Study 35640182 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined orthodonto-surgical treatment
Number of subjects: 83
Study 35640182 — intervention group
Group type: COMPARATOR
Intervention: Removal of individual teeth and retraction of front teeth
Number of subjects: 83
Study 34097759 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-pressure pneumoperitoneum (10 mm Hg)
Number of subjects: 80
Study 34097759 — intervention group
Group type: COMPARATOR
Intervention: Standard-pressure pneumoperitoneum (14 mm Hg)
Number of subjects: 80
Study 32579811 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol (100 to 300 mg daily)
Number of subjects: 369
Study 32579811 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 369
Study 32579811 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol
Number of subjects: 369
Study 35506425 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Information Pack (BIP)
Number of subjects: 31
Study 35506425 — intervention group
Group type: EXPERIMENTAL
Intervention: Extra time with alcohol and drug nurses
Number of subjects: 31
Study 33863276 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-i)
Number of subjects: 32
Study 33863276 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 32
Study 36333742 — intervention group
Group type: EXPERIMENTAL
Intervention: music therapy activities
Number of subjects: 40
Study 36333742 — intervention group
Group type: EXPERIMENTAL
Intervention: community music
Number of subjects: 40
Study 36333742 — intervention group
Group type: EXPERIMENTAL
Intervention: family concerts
Number of subjects: 40
Study 36333742 — intervention group
Group type: COMPARATOR
Intervention: control group
Number of subjects: 40
Study 32722424 — intervention group
Group type: EXPERIMENTAL
Intervention: Choline bitartrate
Number of subjects: 37
Study 32722424 — intervention group
Group type: COMPARATOR
Intervention: No choline control
Number of subjects: 37
Study 32722424 — intervention group
Group type: COMPARATOR
Intervention: Phosphatidylcholine
Number of subjects: 37
Study 32722424 — intervention group
Group type: EXPERIMENTAL
Intervention: Gut microbiota composition
Number of subjects: 37
Study 33906105 — intervention group
Group type: EXPERIMENTAL
Intervention: ROSE trial participation recall
Number of subjects: 487
Study 33906105 — intervention group
Group type: COMPARATOR
Intervention: Study participation recall
Number of subjects: 487
Study 33906105 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month attrition among recalled participants
Number of subjects: 487
Study 33906105 — intervention group
Group type: COMPARATOR
Intervention: 6-month attrition among non-recalled participants
Number of subjects: 487
Study 33906105 — intervention group
Group type: EXPERIMENTAL
Intervention: Reconsent and recall
Number of subjects: 487
Study 32069071 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic supplementation (PRO)
Number of subjects: 7
Study 32069071 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 35545225 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid Intermittent Bolus (RIB) of electrolyte-free solution for 1 hour
Number of subjects: 166
Study 35545225 — intervention group
Group type: COMPARATOR
Intervention: Slow Continuous Infusion (SCI) of electrolyte-free solution continuously
Number of subjects: 166
Study 32087113 — intervention group
Group type: EXPERIMENTAL
Intervention: Contact isolation alongside standard precautions for 12 months
Number of subjects: 15
Study 32087113 — intervention group
Group type: COMPARATOR
Intervention: Standard precautions alone for 12 months
Number of subjects: 15
Study 35305587 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-based cognitive behavioural therapy (FCBT)
Number of subjects: 128
Study 35305587 — intervention group
Group type: COMPARATOR
Intervention: Family-based psychoeducation and relaxation training (FPRT)
Number of subjects: 128
Study 33427179 — intervention group
Group type: EXPERIMENTAL
Intervention: Attachment and Biobehavioral Catch‐Up (ABC) intervention
Number of subjects: 85
Study 33427179 — intervention group
Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 85
Study 33477443 — intervention group
Group type: EXPERIMENTAL
Intervention: Mohana Choorna (Ayurvedic herbal preparation)
Number of subjects: 19
Study 33477443 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 33322022 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg of epigallocatechin gallate (EGCG) and 60 mL of coconut oil daily for 4 months
Number of subjects: 51
Study 33322022 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 51
Study 34074541 — intervention group
Group type: EXPERIMENTAL
Intervention: Bikini incision
Number of subjects: 195
Study 34074541 — intervention group
Group type: COMPARATOR
Intervention: Longitudinal incision
Number of subjects: 195
Study 34074541 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 195
Study 32150661 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus at a dose of 6 mg/m2
Number of subjects: 0
Study 34157162 — intervention group
Group type: EXPERIMENTAL
Intervention: FCL combined with intradermal injection of plasma gel
Number of subjects: 30
Study 34157162 — intervention group
Group type: EXPERIMENTAL
Intervention: FCL combined with topical application of plasma gel
Number of subjects: 30
Study 34157162 — intervention group
Group type: COMPARATOR
Intervention: FCL monotherapy
Number of subjects: 30
Study 34273811 — intervention group
Group type: EXPERIMENTAL
Intervention: Darolutamide 600 mg twice daily
Number of subjects: 1509
Study 34273811 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1509
Study 35115208 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized dietary advice
Number of subjects: 136
Study 32057371 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor plus placebo
Number of subjects: 51
Study 32057371 — intervention group
Group type: COMPARATOR
Intervention: Ticagrelor plus ASA
Number of subjects: 51
Study 36081217 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine for 26 weeks
Number of subjects: 1221
Study 36081217 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1221
Study 36081217 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine and Placebo
Number of subjects: 1221
Study 32974688 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning algorithm for detection of PSC-compatible cholangiographic changes on 3D-MRCP images.
Number of subjects: 428
Study 35772622 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial Photodynamic Therapy with methylene blue (300 µmol/L)
Number of subjects: 108
Study 35772622 — intervention group
Group type: COMPARATOR
Intervention: Antimicrobial Photodynamic Therapy with curcumin (8 µmol/L)
Number of subjects: 108
Study 34607196 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuroaspis PLP10™ (20 ml once daily for 30 months)
Number of subjects: 40
Study 34607196 — intervention group
Group type: COMPARATOR
Intervention: Control (pure virgin olive oil, 20 ml once daily for 30 months)
Number of subjects: 40
Study 35172891 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous imatinib mesylate 200 mg bis in die (b.i.d.) for 7 days
Number of subjects: 90
Study 35172891 — intervention group
Group type: COMPARATOR
Intervention: Placebo IV infusion for 7 days
Number of subjects: 90
Study 32696258 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.4 μg/kg/h IV infusion for 24 h)
Number of subjects: 0
Study 32696258 — intervention group
Group type: COMPARATOR
Intervention: Morphine (10 μg/kg/h IV infusion for 24 h)
Number of subjects: 0
Study 32818647 — intervention group
Group type: EXPERIMENTAL
Intervention: PDT with toluidine blue
Number of subjects: 72
Study 32818647 — intervention group
Group type: EXPERIMENTAL
Intervention: PDT with methylene blue
Number of subjects: 72
Study 32818647 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 72
Study 35183168 — intervention group
Group type: EXPERIMENTAL
Intervention: Subsidized eyeglasses provided to myopic children in treatment schools
Number of subjects: 13100
Study 35183168 — intervention group
Group type: COMPARATOR
Intervention: Prescription information provided without subsidized eyeglasses in control schools
Number of subjects: 13100
Study 33191851 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted volumetry (CAV)
Number of subjects: 517
Study 33191851 — intervention group
Group type: COMPARATOR
Intervention: ABC/2
Number of subjects: 517
Study 33191851 — intervention group
Group type: EXPERIMENTAL
Intervention: Both ABC/2 and CAV
Number of subjects: 517
Study 33191851 — intervention group
Group type: EXPERIMENTAL
Intervention: CAV
Number of subjects: 517
Study 33191851 — intervention group
Group type: EXPERIMENTAL
Intervention: ABC/2 and CAV
Number of subjects: 517
Study 32727831 — intervention group
Group type: EXPERIMENTAL
Intervention: Xpert alone
Number of subjects: 561
Study 32727831 — intervention group
Group type: EXPERIMENTAL
Intervention: LAM alone
Number of subjects: 561
Study 32727831 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential Xpert followed by LAM
Number of subjects: 561
Study 32727831 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent testing with LAM + Xpert
Number of subjects: 561
Study 32727831 — intervention group
Group type: EXPERIMENTAL
Intervention: Any positive TB-specific test
Number of subjects: 561
Study 32727831 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost per TB case diagnosed for sequential and concurrent strategies
Number of subjects: 561
Study 33971606 — intervention group
Group type: EXPERIMENTAL
Intervention: DNA metabarcoding
Number of subjects: 22
Study 33971606 — intervention group
Group type: COMPARATOR
Intervention: Morphological method
Number of subjects: 22
Study 33971606 — intervention group
Group type: EXPERIMENTAL
Intervention: Both approaches
Number of subjects: 22
Study 34905482 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity magnetic stimulation (LIMS) plus standard pharmacological treatment
Number of subjects: 560
Study 34905482 — intervention group
Group type: COMPARATOR
Intervention: Standard pharmacological treatment
Number of subjects: 560
Study 33218519 — intervention group
Group type: EXPERIMENTAL
Intervention: Fascial Manipulation (FM) for the right brachial fascia for 210 seconds
Number of subjects: 60
Study 33218519 — intervention group
Group type: EXPERIMENTAL
Intervention: Fascial Manipulation (FM)
Number of subjects: 60
Study 33218519 — intervention group
Group type: EXPERIMENTAL
Intervention: Static Stretching (SS) of the right biceps brachii for 210 seconds
Number of subjects: 60
Study 33218519 — intervention group
Group type: COMPARATOR
Intervention: Control group (C) supine for 210 seconds
Number of subjects: 60
Study 34039520 — intervention group
Group type: EXPERIMENTAL
Intervention: New classification system for fatty infiltration of the gluteus minimus using plain computed tomography (CT)
Number of subjects: 71
Study 34039520 — intervention group
Group type: COMPARATOR
Intervention: Goutallier classification system
Number of subjects: 71
Study 34039520 — intervention group
Group type: EXPERIMENTAL
Intervention: New classification system for fatty infiltration of the gluteus minimus
Number of subjects: 71
Study 34534858 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT-T (Cognitive Behaviour Therapy emphasizing early behaviour change and body image improvement)
Number of subjects: 98
Study 34534858 — intervention group
Group type: EXPERIMENTAL
Intervention: CBTm (Cognitive Behaviour Therapy including motivational work and no body image content)
Number of subjects: 98
Study 34130959 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction of labour (IoL)
Number of subjects: 871
Study 34130959 — intervention group
Group type: COMPARATOR
Intervention: Expectant management (EM)
Number of subjects: 871
Study 34130959 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurodevelopmental assessment at 10-12 years of age
Number of subjects: 871
Study 34130959 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent questionnaires
Number of subjects: 871
Study 34130959 — intervention group
Group type: EXPERIMENTAL
Intervention: Teacher Report Form
Number of subjects: 871
Study 32678777 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (public speaking anxiety)
Number of subjects: 32
Study 32678777 — intervention group
Group type: COMPARATOR
Intervention: Control group (no stress exposure)
Number of subjects: 32
Study 32495666 — intervention group
Group type: EXPERIMENTAL
Intervention: Permethrin 5% cream applied on two occasions within a one-week interval (Group A)
Number of subjects: 55
Study 32495666 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive application of permethrin 5% cream (Group B)
Number of subjects: 55
Study 32495666 — intervention group
Group type: EXPERIMENTAL
Intervention: Retreatment according to the intense scheme (Group C)
Number of subjects: 55
Study 32777156 — intervention group
Group type: EXPERIMENTAL
Intervention: DCARER system (digital group)
Number of subjects: 143
Study 32777156 — intervention group
Group type: COMPARATOR
Intervention: Traditional method (traditional group)
Number of subjects: 143
Study 36364742 — intervention group
Group type: EXPERIMENTAL
Intervention: NO3−/NO2− supplementation (beetroot juice containing 250 mg nitrate and 20 mg nitrite/day)
Number of subjects: 36
Study 36364742 — intervention group
Group type: EXPERIMENTAL
Intervention: NO3−/NO2− supplementation
Number of subjects: 36
Study 34382886 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-family partnership model
Number of subjects: 0
Study 34403329 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-selected exercise group (SSE)
Number of subjects: 46
Study 34403329 — intervention group
Group type: COMPARATOR
Intervention: Pre-determined exercise group (PDE)
Number of subjects: 46
Study 32562684 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 μg PD01A
Number of subjects: 24
Study 32562684 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 μg PD01A
Number of subjects: 24
Study 32562684 — intervention group
Group type: EXPERIMENTAL
Intervention: Booster immunisation (75 μg)
Number of subjects: 24
Study 32562684 — intervention group
Group type: EXPERIMENTAL
Intervention: All patients (combined)
Number of subjects: 24
Study 32562684 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic treatment-related adverse events
Number of subjects: 24
Study 35026180 — intervention group
Group type: EXPERIMENTAL
Intervention: NTHi-Mcat vaccine
Number of subjects: 606
Study 35026180 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 606
Study 33621322 — intervention group
Group type: EXPERIMENTAL
Intervention: Incentive programs with varying amounts (hypothetical)
Number of subjects: 203
Study 33621322 — intervention group
Group type: EXPERIMENTAL
Intervention: Incentive programs (hypothetical)
Number of subjects: 203
Study 32568400 — intervention group
Group type: EXPERIMENTAL
Intervention: Nocturnal oxygen therapy (NOT) administered at 3 L/min by nasal cannula during nights at 2048 m
Number of subjects: 32
Study 32568400 — intervention group
Group type: COMPARATOR
Intervention: Placebo (room air) administered during nights at 2048 m
Number of subjects: 32
Study 35346534 — intervention group
Group type: EXPERIMENTAL
Intervention: Seeking Safety (cognitive-behavioral intervention for PTSD+SUD)
Number of subjects: 88
Study 35346534 — intervention group
Group type: COMPARATOR
Intervention: Women's Health Education (control)
Number of subjects: 88
Study 32826644 — intervention group
Group type: EXPERIMENTAL
Intervention: KPI-121 0.25%
Number of subjects: 1430
Study 32826644 — intervention group
Group type: COMPARATOR
Intervention: Vehicle drops
Number of subjects: 1430
Study 35415884 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported vaccination status for the season preceding the survey
Number of subjects: 683
Study 35415884 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported vaccination status for the fifth preceding season
Number of subjects: 683
Study 35415884 — intervention group
Group type: EXPERIMENTAL
Intervention: Agreement between self-report and documented vaccination status for the fifth season
Number of subjects: 683
Study 35415884 — intervention group
Group type: EXPERIMENTAL
Intervention: Agreement between self-report and documented vaccination status for the season preceding interview
Number of subjects: 683
Study 35415884 — intervention group
Group type: EXPERIMENTAL
Intervention: Errors in recall for HCP vaccinated for only some of the preceding five seasons
Number of subjects: 683
Study 35415884 — intervention group
Group type: EXPERIMENTAL
Intervention: Errors in recall for HCP vaccinated all five preceding seasons
Number of subjects: 683
Study 34339102 — intervention group
Group type: EXPERIMENTAL
Intervention: Thigh-length elastic pressure socks (intervention group, n=35)
Number of subjects: 70
Study 34339102 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing care (control group, n=35)
Number of subjects: 70
Study 32653015 — intervention group
Group type: COMPARATOR
Intervention: Standard of care only
Number of subjects: 80
Study 32653015 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard of care and lopinavir/ritonavir
Number of subjects: 80
Study 32653015 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard of care and hydroxychloroquine
Number of subjects: 80
Study 35902817 — intervention group
Group type: EXPERIMENTAL
Intervention: SARS‐CoV‐2 vaccines (first two licensed in Switzerland)
Number of subjects: 380
Study 35902817 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial platform implementation
Number of subjects: 380
Study 35902817 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial platform efficiency
Number of subjects: 380